Literature DB >> 23412016

Pelvic floor ultrasonography: an update.

K L Shek1, H-P Dietz.   

Abstract

Female pelvic floor dysfunction encompasses a number of highly prevalent clinical conditions such as female pelvic organ prolapse, urinary and fecal incontinence, and sexual dysfunction. The etiology and pathophysiology of those conditions are, however, not well understood. Recent technological advances have seen a surge in the use of imaging, both in research and clinical practice. Among the techniques available such as sonography, X-ray, computed tomography and magnetic resonance imaging, ultrasound is superior for pelvic floor imaging, especially in the form of perineal or translabial imaging. The technique is safe with no radiation, simple, cheap, easily accessible and provides high spatial and temporal resolutions. Translabial or perineal ultrasound is useful in determining residual urinary volume, detrusor wall thickness, bladder neck mobility and in assessing pelvic organ prolapse as well as levator function and anatomy. It is at least equivalent to other imaging techniques in diagnosing, such diverse conditions as urethral diverticula, rectal intussusception and avulsion of the puborectalis muscle. Ultrasound is the only imaging method capable of visualizing modern slings and mesh implants and may help selecting patients for implant surgery. Delivery-related levator injury seems to be the most important etiological factor for pelvic organ prolapse and recurrence after prolapse surgery, and it is most conveniently diagnosed by pelvic floor ultrasound. This review gives an overview of the methodology. Its main current uses in clinical assessment and research will also be discussed.

Entities:  

Mesh:

Year:  2013        PMID: 23412016

Source DB:  PubMed          Journal:  Minerva Ginecol        ISSN: 0026-4784


  7 in total

1.  Alteration of anal sphincter function in patients with levator avulsion: observational study.

Authors:  María Aubá Guedea; Juan Luis Alcázar Zambrano; Jorge Baixauli Fons; Leire Juez Viana; Begoña Olartecoechea Linaje; Jose Ángel Mínguez Milio
Journal:  Int Urogynecol J       Date:  2015-02-03       Impact factor: 2.894

Review 2.  Does vaginal delivery cause more damage to the pelvic floor than cesarean section as determined by 3D ultrasound evaluation? A systematic review.

Authors:  Camila Carvalho de Araujo; Suelene A Coelho; Paulo Stahlschmidt; Cassia R T Juliato
Journal:  Int Urogynecol J       Date:  2018-03-21       Impact factor: 2.894

3.  Effectiveness of adding voluntary pelvic floor muscle contraction to a Pilates exercise program: an assessor-masked randomized controlled trial.

Authors:  Luiza Torelli; Zsuzsanna Ilona Katalin de Jarmy Di Bella; Claudinei Alves Rodrigues; Liliana Stüpp; Manoel João Batista Castello Girão; Marair Gracio Ferreira Sartori
Journal:  Int Urogynecol J       Date:  2016-06-01       Impact factor: 2.894

4.  Three-dimensional ultrasound appearance of pelvic floor in nulliparous women and postpartum women one week after their first delivery.

Authors:  Feifei Liu; Lian Xu; Tao Ying; Junjia Tao; Bing Hu
Journal:  Int J Med Sci       Date:  2014-01-11       Impact factor: 3.738

5.  Relationship among vaginal palpation, vaginal squeeze pressure, electromyographic and ultrasonographic variables of female pelvic floor muscles.

Authors:  Vanessa S Pereira; Humberto S Hirakawa; Ana B Oliveira; Patricia Driusso
Journal:  Braz J Phys Ther       Date:  2014-10-10       Impact factor: 3.377

6.  Prevalence of pelvic organ prolapse and related factors in a general female population.

Authors:  Hakan Aytan; Devrim Ertunç; Ekrem C Tok; Osman Yaşa; Hakan Nazik
Journal:  Turk J Obstet Gynecol       Date:  2014-09-15

Review 7.  Muscular changes after minimally invasive versus open spinal stabilization of thoracolumbar fractures: A literature review.

Authors:  Miguel Pishnamaz; Ulrike Schemmann; Christian Herren; Klemens Horst; Philipp Lichte; Frank Hildebrand; Hans-Christoph Pape; Philipp Kobbe
Journal:  J Musculoskelet Neuronal Interact       Date:  2018-03-01       Impact factor: 2.041

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.